From Innovation to Solutions: Childhood Influenza Vaccination Planning
|ClinicalTrials.gov Identifier: NCT01664793|
Recruitment Status : Completed
First Posted : August 14, 2012
Results First Posted : November 24, 2014
Last Update Posted : November 24, 2014
|Condition or disease||Intervention/treatment|
|Influenza||Behavioral: 4 Pillars Immunization Toolkit|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||87665 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vaccination Assessment as a Vital Sign to Increase Childhood Influenza Vaccination in Diverse Settings|
|Study Start Date :||October 2010|
|Primary Completion Date :||February 2013|
|Study Completion Date :||November 2013|
Experimental: Intervention Group Year 1
The 4 Pillars Immunization Toolkit along with donated vaccines for early season vaccination, staff education and support.
Behavioral: 4 Pillars Immunization Toolkit
Pillar 1: Convenient Vaccination Services; Pillar 2: Patient notification about the importance of vaccination and availability of convenient services; Pillar 3: Enhanced Office Systems; Pillar 4: Motivation: Office immunization champion tracks progress towards a goal; Early delivery of donated vaccines for disadvantaged children, staff education, support of effort by research staff.
No Intervention: Control Group Year 1
Control sites will not receive assistance with increasing influenza vaccination in Year 1, they will follow guidelines for usual care.
- Primary Outcome [ Time Frame: 3/1/2011-2/29/2012 ]Influenza vaccination rates in each arm at the end of year 1
- Effectiveness Score [ Time Frame: End of February 2012 ]Two staff members from each site were surveyed as to usefulness/effectiveness of a list of strategies recommended in the toolkit to increase vaccination rates. Values (range = 1-100 with 1 being not at all effective and 100 being highly effective) were averaged and used as an effectiveness score for each strategy. The average value for each site was combined with all sites and averaged for each strategy. (actual range = 20.6-90.7).
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01664793
|United States, Pennsylvania|
|University of Pittsburgh, School of Medicine, Deparment of Family Medicine and Clinical Epidemiology|
|Pittsburgh, Pennsylvania, United States, 15213|
|Principal Investigator:||Richard Zimmerman, MD, MPH||University of Pittsburgh, School of Medicine, Department of Family Medicine and Clinical Epidemiology|
|Study Director:||Chyongchiou Lin, PhD||University of Pittsburgh|